Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshiyuki Hatakeyama is active.

Publication


Featured researches published by Toshiyuki Hatakeyama.


European Surgical Research | 2000

Susceptibility to lipopolysaccharide of cholestatic rat liver produced with bile duct ligation: assessments of the mitochondrial glutathione pool and the effects of N-acetylcysteine.

Hiroshi Nakano; Y. Fujiwara; N. Kitamura; Kaoru Kumada; Akihiko Matsumiya; Hitoshi Sakai; Toshiyuki Hatakeyama; Masahiko Yamaguchi; Daniel Jaeck

We investigated whether rats with obstructive jaundice produced with bile duct ligation for 2 weeks are more susceptible to the additional stress of lipopolysaccharide (LPS) administration than sham-operated rats and also examined the effects of N-acetylcysteine (NAC) on LPS stimulation in rats with bile duct ligation. The effects of LPS on the mitochondrial glutathione pool and on oxidative stress of polymorphonuclear leukocytes were investigated in cholestatic rats. Serum concentrations of α-glutathione S-transferase showed that lipopolysaccharide stimulation caused more severe hepatocellular injury in cholestatic rats than in sham-operated rats. In addition, concentrations of mitochondrial reduced and oxidized glutathione and hepatic adenosine triphosphate showed that LPS stimulation decreased mitochondrial function more in cholestatic rats than in sham-operated rats. Intraperitoneal administration of NAC for 2 weeks significantly improved mitochondrial function and decreased hepatocellular injury. However, the oxidative stress of polymorphonuclear leukocytes that had infiltrated hepatic tissue was increased by NAC. The present results indicate that the cholestatic liver is susceptible to the additional stress of LPS, that NAC suppresses the adverse effects of LPS in cholestatic livers, and that the oxidative stress of polymorphonuclear leukocytes is not significantly involved in mitochondrial dysfunction or hepatocellular injury in this model.


European Surgical Research | 1999

Prevention of reactive oxygen-induced endothelial cell injury by blocking its process.

H Shimura; Masahiko Yamaguchi; M Kuzume; Akihiko Matsumiya; Tadashi Matsumoto; Hitoshi Sakai; Toshiyuki Hatakeyama; Hiroshi Nakano; Kaoru Kumada; Takemasa Midorikawa; Yasuo Yoshizawa; Yutaka Sanada; Hisayuki Ohata; Hiroshi Sakagami; Minoru Takeda

Endothelial cell (EC) injury induced by reactive oxygen species (ROS) was investigated and effects of Ca<sup>2+</sup> channel blockers, agents which elevate intracellular cAMP levels ([cAMP]<sub>i</sub>), and protein kinase inhibitors on H<sub>2</sub>O<sub>2</sub>-induced EC injury were analyzed using human umbilical vein EC cultures. Exposure to H<sub>2</sub>O<sub>2</sub> increased intracellular Ca<sup>2+</sup> levels and decreased [cAMP]<sub>i</sub>. Ca<sup>2+</sup> channel blockers, [cAMP]<sub>i</sub>-elevating agents, and protein kinase inhibitors significantly inhibited H<sub>2</sub>O<sub>2</sub>-induced EC injury. Data suggest that H<sub>2</sub>O<sub>2</sub>-induced EC injury is mediated by extracellular Ca<sup>2+</sup> influx, intracellular cAMP efflux, and intracellular signaling, each of which is blocked by Ca<sup>2+</sup> channel blockers, [cAMP]<sub>i</sub>-elevating agents, or protein kinase inhibitors. It is suggested that ischemia/reperfusion injury induced by ROS may be prevented by Ca<sup>2+</sup> channel blockers, [cAMP]<sub>i</sub>-elevating agents, and protein kinase inhibitors.


World Journal of Gastroenterology | 2008

Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases.

Hiroshi Nakano; Yasuo Ishida; Toshiyuki Hatakeyama; Kazuma Sakuraba; Masahiro Hayashi; Osamu Sakurai; Kiyoshi Hataya


European Journal of Surgery | 2000

Improvement of Portal Flow and Hepatic Microcirculatory Tissue Flow with N-acetylcysteine in Dogs with Obstructive Jaundice Produced by Bile Duct Ligation

Gaku Kigawa; Hiroshi Nakano; Kaoru Kumada; N. Kitamura; Sei Takeuchi; Toshiyuki Hatakeyama; Masahiko Yamaguchi; Hideaki Nagasaki; Karim Boudjema; Daniel Jaeck


Hepato-gastroenterology | 1999

Administration of prostaglandin E1 reduces post-operative hepatocellular damage and restores hepatic integrity in patients undergoing hepatectomy.

Baek Y; Hiroshi Nakano; Kaoru Kumada; Hideaki Nagasaki; Gaku Kigawa; Sasaki J; Kaneda M; Toshiyuki Hatakeyama; Kitamura N; Yutaka Sanada; Takemasa Midorikawa; Masahiko Yamaguchi


Annals of Thoracic and Cardiovascular Surgery | 2009

Epidural pneumatosis associated with pneumomediastinum occurring at rest.

Makoto Nonaka; Toshiyuki Hatakeyama; Ichiro Okada; Kazuma Sakuraba; Yuri Tomita; Sumito Sato; Junichi Oga; Yasuo Ishida; Kiyoshi Hataya


The Showa University Journal of Medical Sciences | 2005

Case Report of a Patient with a Favorable Prognosis Following Excision of a Metastatic Inguinal Sac Tumor Originating from Cecum Cancer

Takahiro Umemoto; Takemasa Midorikawa; Kazuyoshi Ishibashi; Kiyoshi Miyakawa; Toshiyuki Hatakeyama; Kouji Maezawa; Osamu Uemichi; Katsumi Makita; Hitoshi Soda; Yutaka Sanada


Hepato-gastroenterology | 2004

Microwave coagulation therapy for a liver tumor involving the root of the left hepatic vein of the residual liver after extended right hepatectomy

Takemasa Midorikawa; Hiroaki Kikuchi; Kazuyoshi Ishibashi; Mitsuo Saito; Toshiyuki Hatakeyama; Shigeki Kadokura; Tadashi Matsumoto; Kiyoshi Miyakawa; Kouji Maezawa; Osamu Uemichi; Hisayuki Izuno; Kunitoshi Aita; Hiroshi Nemoto; Hideaki Nagasaki; Hidefumi Yagi


The Showa University Journal of Medical Sciences | 2004

Endoscopic Treatment of the Large Intestine Endoscopic Balloon Dilatation for Treating Postoperative Anastomotic Strictures in the Large Intestine

Hisashi Oka; Toshiyuki Hatakeyama; Hiroshi Machida; Akihiko Matsumiya; Hisanori Itsuno; Akio Nakayoshi; Norihiro Kaminaga; Takayuki Urakami; Yutaka Endo; Rikiya Fujita


Hepato-gastroenterology | 2004

Is fenestration a safe treatment for adult polycystic liver disease?: A report of refractory complications.

Kazuyoshi Ishibashi; Takemasa Midorikawa; Hiroaki Kikuchi; Yasurou Fujiwara; Hisanori Izuno; Toshiyuki Hatakeyama; Mitsuo Saito; Kiyoshi Miyakawa; Hiroaki Mizukami; Kouji Maezawa; Hiroshi Nemoto; Yutaka Sanada

Collaboration


Dive into the Toshiyuki Hatakeyama's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge